CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7005 result(s)

Efalizumab (Raptiva)

Last Updated: October 25, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Efalizumab
Indications: Psoriasis, moderate to severe chronic plaque

  • Brand Name: Raptiva
  • Manufacturer: Serono Canada Inc.
  • Project Number: S0043
  • Project Status: Complete
  • Submission Type: New

CT and MRI for Selected Clinical Disorders: a Systematic Review of Clinical Systematic Reviews

Last Updated: October 21, 2005
Result type: Reports

Technology Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). Disease This report explores 13 conditions for which the use of CT and MRI remain controversial: arteriovenous malformations carotid artery disease, cerebral aneurysms, coronary artery disease, headaches, head injuries, lung cancer screening, peripheral vascular disease...

Roflumilast for Asthma and Chronic Obstructive Pulmonary Disease

Last Updated: October 21, 2005
Result type: Reports

Roflumilast is an inhibitor of phosphodiesterase-IV (PDE4), a cellular enzyme that is linked to airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). n clinical trials, roflumilast produced significant improvements in FEV1 (forced expiratory volume in one second) and PEF (peak expiratory flow) compared wit...

Pegaptanib sodium (Macugen)

Last Updated: October 20, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Pegaptanib sodium
Indications: Macular degeneration, age-related

  • Brand Name: Macugen
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0044
  • Project Status: Complete
  • Submission Type: New

Niacin/lovastatin (Advicor)

Last Updated: October 18, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Niacin/lovastatin
Indications: Hypercholesterolemia and mixed dyslipidemia

  • Brand Name: Advicor
  • Manufacturer: Oryx Pharmaceuticals Inc.
  • Project Number: S0042
  • Project Status: Complete
  • Submission Type: New

Omalizumab (Xolair)

Last Updated: October 13, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Omalizumab
Indications: Asthma, severe persistent

  • Brand Name: Xolair
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: S0045
  • Project Status: Complete
  • Submission Type: Resubmission

Automated External Defibrillators for Home Use

Last Updated: September 15, 2005
Result type: Reports

The Philips HeartStart Home Defibrillator is an automated external defibrillator (AED) that is approved for home use by untrained users. Most cardiac arrests occur in the home, so a rapid response with cardiopulmonary resuscitation (CPR) and defibrillation is critical for survival. No prospective studies demonstrate that the use of AEDs in th...

Abatacept as Add-on Therapy for Rheumatoid Arthritis

Last Updated: September 8, 2005
Result type: Reports

Abatacept is a co-stimulation blocker that inhibits T-cell activation and interrupts the process leading to inflammation in rheumatoid arthritis. Patients with severe arthritis who took abatacept with at least one other diseasemodifying antirheumatic drug in six and 12-month clinical trials demonstrated statistically significant improvement i...